Form 8-K - Current report:
SEC Accession No. 0001181431-09-005524
Filing Date
2009-01-30
Accepted
2009-01-30 16:40:07
Documents
3
Period of Report
2009-01-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K REPORTING SV TRANSACTION rrd231423.htm 8-K 7903
2 rrd231423_27251.htm EX-10.1 49893
3 rrd231423_27252.htm EX-10.2 11998
  Complete submission text file 0001181431-09-005524.txt   71853
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 919-861-0202
DARA BioSciences, Inc. (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23776 | Film No.: 09558813
SIC: 2834 Pharmaceutical Preparations